Consolidated Statement Of Income

KYORIN Pharmaceutical Co., Ltd. - Filing #7731582

Concept 2017-04-01 to
2017-09-30
2017-04-01 to
2017-09-30
2017-04-01 to
2017-09-30
2017-04-01 to
2017-09-30
2017-04-01 to
2017-09-30
2016-04-01 to
2016-09-30
2016-04-01 to
2016-09-30
2016-04-01 to
2016-09-30
2016-04-01 to
2016-09-30
2016-04-01 to
2016-09-30
Consolidated statement of income
Statement of income
Ordinary income
Other operating income
Share of profit of entities accounted for using equity method
9,000,000 JPY
11,000,000 JPY
Net sales
47,977,000,000 JPY
50,759,000,000 JPY
2,781,000,000 JPY
0 JPY
50,758,000,000 JPY
54,639,000,000 JPY
54,628,000,000 JPY
-11,000,000 JPY
51,947,000,000 JPY
2,692,000,000 JPY
Cost of sales
23,128,000,000 JPY
23,830,000,000 JPY
Operating expenses
Selling, general and administrative expenses
26,186,000,000 JPY
27,134,000,000 JPY
Operating expenses
Gross profit (loss)
27,630,000,000 JPY
30,797,000,000 JPY
Ordinary profit (loss)
1,693,000,000 JPY
3,921,000,000 JPY
Operating expenses
Research and development expenses
7,179,000,000 JPY
7,327,000,000 JPY
Operating profit (loss)
1,222,000,000 JPY
1,297,000,000 JPY
75,000,000 JPY
145,000,000 JPY
1,443,000,000 JPY
3,531,000,000 JPY
3,663,000,000 JPY
131,000,000 JPY
3,559,000,000 JPY
-27,000,000 JPY
Net sales
Cost of sales
Selling, general and administrative expenses
Non-operating income
Interest income
11,000,000 JPY
8,000,000 JPY
Dividend income
189,000,000 JPY
187,000,000 JPY
Other
114,000,000 JPY
67,000,000 JPY
Non-operating income
325,000,000 JPY
276,000,000 JPY
Extraordinary income
627,000,000 JPY
0 JPY
Extraordinary losses
420,000,000 JPY
88,000,000 JPY
Non-operating expenses
Interest expenses
13,000,000 JPY
14,000,000 JPY
Other
2,000,000 JPY
3,000,000 JPY
Non-operating expenses
75,000,000 JPY
17,000,000 JPY
Profit (loss) before income taxes
1,900,000,000 JPY
3,833,000,000 JPY
Gross profit
Extraordinary income
Gain on sale of non-current assets
50,000,000 JPY
JPY
Gain on sale of investment securities
JPY
0 JPY
Income taxes - current
487,000,000 JPY
679,000,000 JPY
Income taxes - deferred
172,000,000 JPY
468,000,000 JPY
Extraordinary losses
Income taxes
659,000,000 JPY
1,148,000,000 JPY
Profit (loss)
1,240,000,000 JPY
2,684,000,000 JPY
Profit (loss) attributable to owners of parent
1,240,000,000 JPY
2,684,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
668,000,000 JPY
-2,825,000,000 JPY
Foreign currency translation adjustment
-47,000,000 JPY
-200,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
4,000,000 JPY
3,000,000 JPY
Remeasurements of defined benefit plans, net of tax
316,000,000 JPY
330,000,000 JPY
Other comprehensive income
941,000,000 JPY
-2,692,000,000 JPY
Profit attributable to
Comprehensive income
2,181,000,000 JPY
-8,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
2,181,000,000 JPY
-8,000,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.